Growing alarm about delta-8 THC products in the US, and reports of it being prescribed to patients in Australia, have prompted industry bodies to warn members about the risks associated with the cannabinoid and to raise their concerns with regulators.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login

Last month, the US Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention (CDC) issued warnings about delta-8 after it emerged more than 100 people had been hospitalised in 2021 having consumed products containing the cannabinoid.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Hannah Adler

hannah@cannabiz.com.au

Hannah is a communications professional and early-career researcher in the disciplines of health communication and health sociology. She is a PhD student at Griffith University currently writing a...